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The  basic  fact  that  infections with  the  typhoid bacillus  can  be 
prevented by vaccination is, of course, well established by clinical evi- 
dence.  It  is  also  supported, theoretically, by a  certain  amount  of 
experimental evidence.  Problems still remain, however, in regard to 
the degree and duration of immunity, the best kind of vaccine, its 
keeping qualities, and the best method of administration.  The experi- 
mental solution of these problems has been delayed by the impossi- 
bLllty of reproducing  a true typhoid infection in the common  laboratory 
animals.  In the absence of a  real protection test, efforts have been 
made to settle many questions by a quantitative determination of the 
antibody content of the serum of vaccinated animals.  This method 
has been of practical value in some directions, but of course, in general, 
is inferior to an actual protection test.  As an illustration of the limi- 
tations of the antibody method, it may be stated that typhoid vaccine, 
10 years old, produces almost as  good an agglutination titer in the 
rabbit as fresh vaccine, but its protective value is much less. 
Another method of testing immunity has been the use of typhoid 
intoxication in the common laboratory animals.  By intravenous or 
intraperitoneal injections of living bacilli, differences in toxicity can 
be determined in different strains of the typhoid bacillus and protection 
by  vaccination can  be  demonstrated.  This method also  has  some 
value, but it is highly artificial, as the doses are usually enormous and 
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there is no true septicemia.  The  same is true  of the  Gay method of 
using gall bladder infections as a  test of immunity. 
In recent years the discovery of the natural occurrence  of paratyphoid infec- 
tions in animals as well as in man has opened the way for actual protection tests 
with this group of organisms.  Clinically,  paratyphoid vaccination is as  effective 
as  typhoid vaccination and  there  seems to  be no  reason why  the  information 
obtained from vaccination with  the paratyphoid group of bacilli should  not be 
applied to  the whole  Salmonella group.  This method has recently been used, 
experimentally, by Besredka  (1)  in developing his  ideas on local immunity and 
by Flexner and Amoss (2),  Webster (3),  and Lynch (4)  in epidemiological  work 
among mice.  We have also used  this method for several years in  attempting 
to solve some of the problems mentioned above, in connection with the manu- 
facture of large amounts of triple typhoid vaccine at the Army Medical School. 
Even this method, in our hands, is somewhat artificial,  but the results are none 
the less definite and valuable. 
Considerable  work along the same lines  has been done with  other groups of 
organisms,  especially the  Pasteurella  group.  The  most  extensive recent  work 
has  been  that  of  Harvey  (5),  who worked with pigeons  and after vaccination 
with  B.  avisepticus, gave intravenous  infecting  doses.  He concludes  (a)  that 
an avirulent organism protects as well as a virulent one, (b) that multiple small 
doses protect better than one large dose, (c) that there is some group and non- 
specific protection, and  (d)  that vaccine does not deteriorate with age or tem- 
perature up to 6 to 9 months. 
Our work started in  1921  with  a  spontaneous  and  severe epidemic 
among guinea pigs,  which  furnished  us with a  picture  of the  natural 
disease.  The causative organism was the "mutton"  strain of Bacillus 
aertrycke,  which  can  be  differentiated  from  the  human  paratyphoid 
B  bacillus only by absorption of agglutinins. 
Method. 
Male  guinea pigs  of approximately the  same weight were selected 
and kept under  observation for about a  week.  They were then vac- 
cinated,  subcutaneously,  at  8  to  10  day intervals  and  15  days  after 
the  last  dose  of  vaccine  were  given  the  infecting  dose,  also 
subcutaneously. 
This dose was about 400 million organisms.  The virulence was such that the 
controls died in  6  to  10  days.  Each animal that died was autopsied and  the 
lesions  were noted and cultures were made from the spleen,  liver, gall bladder, 
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days and similar cultures were made.  The organisms were identified  by agglu- 
tination.  A  few  surviving  animals  showed  possible  residua  of  infection  with 
negative Cultures,  and  were  considered  not  infected.  Precautions  were  taken 
to avoid sudden drop in animal room temperature which  is often followed by a 
number of deaths from non-specific pneumonia. 
Careful adjustment of the virulence of the virus is necessary and several pre- 
liminary series were lost through failure to observe this point.  In one series, all 
the vaccinated animals died as well as all the controls,  although the vaccinated 
animals lived longer and  had  less  extensive lesions.  In another series, none of 
the controls became infected.  It was finally found that by making blood cultures 
from sick  animals and by transplanting to blood broth,  the virulence could be 
maintained  at  a  fairly  fixed  po.'mt.  The  infecting  doses  were  made  from  18 
hour blood broth cultures.  In each experiment, as far as possible,  four animals 
were used,  with four normal controls,  and four controls vaccinated with fresh, 
full strength, saline vaccine, 1 cc. of which contained about 1,000 million organisms. 
An attempt was made to imitate natural conditions  by feeding bacilli and by 
inoculation  of the alimentary tract by means of a  medicine  dropper and fairly 
good results were obtained in one series,  but this method was given up for the 
subcutaneous one, on account of more certainty of infection. 
The  animals  all  developed  a  local lesion at the  site  of inoculation 
consisting  of  a  suppurating  nodule  which  usually  broke  down  and 
discharged.  In normal animals this lesion was large and edematous; 
the animals appeared sick and usually had a  conjunctivitis.  In pro- 
tected animals, the lesion was sharply localized and no systemic reac- 
tion was noted.  The specific internal lesions in non-protected animals 
consist of an enlarged and  granular  spleen  and liver, an infected  gall 
bladder,  and usually a  pneumonia. 1 
Control Experiments  with Full Strength Fresh Saline Vaccine. 
TABLE  I. 
No. of  Group.  anlmals. I 
[ -- 
Control  ........................................  12  [ 
i 
Vaccinated (2,500 million)  .......................  11  I 
Protected.  Not 
protected. 
o  12 
11  o 
These results were all clean-cut;  the  controls all died of  the  acute 
disease and all cultures were positive except in one instance of death on 
1 The experimental stock was obtained by courtesy of the United States De- 
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the 27th day in which the organisms were found only in the gall bladder 
contents (Table  I).  None  of  the  vaccinated  animals  showed  any 
signs  of  disease  except  locally.  The  vaccinating  doses  were  500, 
1,000~ and  1,000 million bacilli  subcutaneously at 8  day intervals,  a 
total of 2,500 million organisms.  This technique affords, therefore, a 
definite method by which it is possible to secure reliable data on various 
questions. 
Relation of Dose of Vaccine to Protection. 
The doses used to vaccinate animals  are  usually the  same as  for 
adult human beings and of course are  enormously larger  than  com- 
parative body weight would call  for.  The infecting dose, however, is 
also much larger than the proportionate dose for man.  But the effect 
of different sized doses of vaccine is instructive. 
TABLE  II. 
Total No. of  organisms injected.  No. of  animals.  Protected.  Not protected. 
625 million.  4  3  1 
300  "  3  1  2 
25  ."  3  1  2 
The  vaccine was  given in  the  regular way in  three  doses  of 0.5, 
1.0, and 1.0 cc.  The dose in the third experiment, is the adult human 
dose  reduced  approximately  to  body  weight  for  the  guinea  pig. 
Only one out of three animals was protected (Table II).  All the ani- 
mals in this series, which are marked not protected, died of the disease, 
with positive  cultures.  It  is  seen  again  that  the  protection  varies 
with the number of organisms injected. 
Effect of Age of Vaccine on Protection. 
The question of the keeping power of prophylactic vaccines is of 
importance, economically, as well  as immunologically.  Attempts to 
settle this question by antibody production are not convincing.  As 
will be seen from Table III, there is a  falling off of protection after 8 
months and we believe that this is about the time limit for this kind of 
vacdne. HENRY  7,  NICHOLS  AND  CLARENCE  O.  STIMMEL 
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4  t 
100 per cent protection. 
il 66 per cent protection. 
All the animals marked not protected died of the disease, except one 
of the 11 months series, which survived but on autopsy showed lesions, 
with organisms, in the spleen and gall bladder.  The vaccine was kept 
under conditions which resembled those of actual use, part of the time 
at room temperature and part of the time in the ice box, with occasional 
shaking.  It is  seen that vaccine up to 8 months old gave  complete 
protection in twenty-two animals.  Vaccine 10 to 14 months old pro- 
tected only eight out of twelve animals, a  falling off of one-third in 
protective power. 
Effect of Different Kinds of Vaccine. 
The exact kind of vaccine has, of course, been the subject of much 
work  and  discussion.  Our  results  with several  different kinds  are 
given in Table IV. 
TABLE  IV. 
Vaccine. 
Lipovaccine (2,500 million).. 
Resuspended vaccine 
Supernatant fluid 
Sensitized vaccine (killed) 
T. A. B. vaccine. 
No. of animals.  Protected.  Not  protected. 
Lipo~acdne.--The animals were given a single dose in oil equal to the divided 
saline doses.  All  the  animals survived, but  two on  autopsy  showed specific 
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Resuspended  Vaccine.--The vaccine was  allowed  to stand for about  14 days 
in 5 cc. ampules  until  the supernatant fluid  was  crystal-clear.  This fluid  was 
pipetted off and the sediment was resuspended  in an equal amount of salt solu- 
tion.  The results were  as good as with  the original  vaccine. 
Supernatant  Fluid.--The  supernatant  fluid,  obtained  as  stated  above, was 
used as a  vaccine.  This fraction has some protective power,  but  one  animal 
died of the disease and one of three surviving animals was  infected. 
Sensitized Killed  Vacdne.--This was apparently not so effective as  the original 
vaccine,  as one animal died of typhoid disease.  Four animals,  given a  living 
sensitized vaccine,  all died of the disease contracted from the first dose of vac- 
cine. 
T. A. B. Vaccine.--This  group vaccine protected fully.  The total Para B dose 
was  1,250 million,  Para A,  1,250 million,  and  typhoid, 2,500 million. 
We also have some partial data which tend to show that detoxicated 
(6) and filtered vaccines do not protect so well as the original vaccine. 
Our work on vaccination by mouth (Besredka) is too incomplete to be 
discussed, but Webster  (3), working with the same organism in mice, 
found no evidence of local immunity. 
DISCUSSION. 
The  experimental work  cited  above  supports the  following conclu- 
sions and general rules for practise in prophylactic vaccination against 
the typhoid group of infections.  It may appear that some of this work 
is superfluous, as several of the conclusions reached are already accepted, 
but it seems desirable to record ail the actual evidence obtainable. 
1.  Acquired  immunity is  a  variable  factor and  depends  partly on 
the dose of vaccine.  A high immunity can be obtained by a sufficient 
vaccination but  can be  overcome by a  large  enough  infecting dose. 
Repeated  doses  give  better  immunity  than  a  single  dose.  It  is 
probably also true that frequent courses give the greatest protection, 
which is probably the reason for the freedom of the Army from these 
infections.  According  to  regulations,  vaccination  is  given  every  3 
years for three courses.  But not infrequently records are lost and vac- 
cinations are repeated oftener than called for. 
2.  A relatively fresh vaccine gives better protection than an old one; 
the period of maximum efficiency is about the first 8 months. 
3.  Plain saline vaccine is superior to lipovaccine, sensitized vaccine, 
or  some  fractions.  Vaccination  with  sensitized  living  vaccine  pro- 
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The  principal  point  of  interest  in  this  connection is  probably  in 
regard  to the use of lipovaccine.  It is not intended to  discuss the 
subject fully here, but it may be said that the use of lipovaccine was 
discontinued in the Army, primarily,  on account of the difficulty of 
making a sterile product on a large scale.  When methods were  avail- 
able for making a sterile vaccine, lipovaccine was not reissued because 
of doubts as to its protective power.  As judged by the production of 
antibodies, it is distinctly inferior to saline vaccine (7).  Judged by the 
present method it undoubtedly gives some protection and in an emer-: 
gency might be used on account of the definite advantages of a single 
dose.  The best protection, however, is afforded by  multiple doses of- 
a saline vaccine. 
The subject of group and non-specific immunity has  come to  the 
front  recently.  A  partial  non-specific protection  has  been  demon- 
strated  experimentally by Harvey  (5),  by  Clark  (8),  and by others. 
According  to  the  results  given  above,  a  group  vaccine  proved  as 
effective as the specific vaccine.  It should be remembered, however, 
that  the  human  Para  B bacillus  is very closely related  to  Bacillus 
aertrycke.  In our Service,  on  the  Mexican  Border  before the War, 
typhoid vaccine, alone, gave no adequate protection against infections 
with Para  A  and  B.  During the war,  the  same  fact was  demon- 
strated  in the British Army and a  paratyphoid vaccine was  insisted 
on and proved effective. 
SUMMARY. 
I.  A natural infection of guinea pigs with  the "mutton" strain  of 
Bacillus aertrycke was used to test the protective power of vaccination 
against the typhoid group of infections. 
2.  Under the conditions of the experiment, complete protection was 
secured by vaccination with full strength fresh saline vaccine, while 
I00 per cent of deaths occurred among the controls. 
3.  The immunity acquired is variable and depends on the number of 
organisms injected. 
4.  Vaccine kept 10 to 14 months gave less protection than vaccine 
8 months old and under. 
5.  Saline  vaccine  was  more  effective  than  lipovaccine,  sensitized 
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6.  Resuspended vaccine was as effective as the original vaccine. 
7.  In one experiment, group vaccine, made of typhoid Para A  and 
Para B bacilli, was as effective as the original specific vaccine. 
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